Canna River Review

What to check before you buy

• •Be clear which of the three ranges your basket is actually from
• •Check your state on both kratom and intoxicating hemp — no restricted list was visible to us
• •Open the published COA and compare cannabinoid figures to the label
• •Do not use the Delta-8, Delta-9 or kratom products if you are drug tested
• •Buy intoxicating hemp for near-term use rather than stocking up before 12 November
• •Tell your prescriber if you take a GLP-1, and skip the kratom line entirely

Is Canna River the same company as River Botanicals?

Yes. The site states plainly: 'Canna River is now DBA River Botanicals. With this update, there is no change of ownership.' River Botanicals launched in July 2026 as a parent brand housing Canna River alongside other lines, with the company describing it as the same team, the same price points and the same quality controls, positioning itself to sell botanical products beyond cannabinoids over time. Existing Canna River products continue. Worth knowing because the website listed against this affiliate offer now redirects to the new domain — that is a rebrand, not a red flag, and the company has been upfront about it.

What exactly does it sell?

Three quite different things, and this is the most important thing to understand before ordering. First, non-intoxicating hemp: CBD, CBN and CBG in tinctures, softgels, gummies, topicals and pet products — a CBD Classic Tincture was $20 and CBD sleep gummies $35 when we checked. Second, intoxicating hemp: Delta-8 and Delta-9 products including gummies at around $30 and beverages, which will get you high and can cause a positive drug test. Third, and separately branded as Kratom River: kratom gummies, shots and tablets, with gummies around $50. Those are three distinct risk categories sharing one storefront, and a buyer who came for a CBD tincture should not drift into the kratom range without understanding what it is.

Is the labelled potency accurate?

There is a documented question about it. Forbes Health runs an independent CBD testing programme, and its testing of Canna River found that the company's own certificate of analysis claimed a higher amount of CBD per package than the independent lab measured. Separately, some third-party reporting has found certain products testing above their advertised cannabinoid content — by 20 to 25% in some cases — which is a labelling inaccuracy in the other direction and not necessarily a bad thing for the user, though it still means the label is not a reliable guide to the dose. Taken together, the sensible reading is that Canna River publishes COAs and names a real laboratory, which is more than many brands do, but that you should treat the printed milligram figure as approximate and read the batch report rather than trusting the box.

Should I be concerned about the kratom line?

You should at least know what it is, because it is a categorically different product from CBD. Kratom's principal alkaloids act on opioid receptors. The FDA advises consumers not to use kratom, citing liver toxicity, seizures, substance use disorder and death; it produces genuine physical dependence and withdrawal with regular use; and the CDC reported in March 2026 that kratom-involved poisonings and hospitalisations had risen by more than 1,200% over the previous decade. It is banned outright in eight states — Alabama, Arkansas, Indiana, Louisiana, Vermont, Wisconsin, Connecticut and Tennessee. Buying a kratom gummy from a shop you visited for a CBD tincture is an easy mistake to make when both sit in the same catalogue, and it is worth naming clearly. If you take a GLP-1, there is an additional reason to avoid it — see below.

Can I use any of this alongside a GLP-1?

Ask your prescriber, and be specific about which product. For CBD: it inhibits several liver enzymes that metabolise many prescription drugs — GLP-1s are peptides and are not primarily cleared that way, so the direct interaction is limited, but CBD can cause diarrhoea and appetite changes that overlap confusingly with GLP-1 side effects. For Delta-8 or Delta-9: THC stimulates appetite, which works directly against what your medication is doing, and GLP-1s slow gastric emptying, which makes an edible's onset unpredictable. For kratom: this is the one to avoid. Kratom's opioid-receptor activity makes constipation a hallmark effect, and GLP-1 medications independently cause constipation — stacking them raises the risk of severe constipation, and both cause nausea, which can mask abdominal symptoms that matter clinically on a GLP-1.

What changes on 12 November 2026?

Congress narrowed the federal definition of hemp in December 2025, and from 12 November 2026 hemp means no more than 0.3% total THC rather than delta-9 alone, with synthetic cannabinoids excluded. That change targets intoxicating hemp products. Canna River's CBD, CBN and CBG lines should be largely unaffected; its Delta-8 products are directly in scope, since delta-8 is typically converted from CBD, and its Delta-9 edibles rely on the by-weight percentage the total-THC standard was written to close. Federal agencies have not published detailed enforcement guidance, so the practical effect is uncertain — but buy the intoxicating products for near-term use rather than stocking up, and note that the kratom line is governed by an entirely separate and also-shifting set of rules.

Does any of this help with weight loss?

No. Neither CBD nor kratom has a credible evidence base for weight loss, and Canna River does not market either that way — its site carries the standard disclaimer that products are not intended to diagnose, treat or cure any disease. THC actively increases appetite, which is the opposite of what a GLP-1 does. If you arrived here from a weight-loss search, nothing in this catalogue addresses that, and the kratom products in particular carry risks that make them a poor thing to experiment with while managing a medical treatment.

Who should avoid these products?

For the hemp products: anyone pregnant, trying to conceive or breastfeeding; anyone under 21; anyone with liver disease, since CBD can raise liver enzymes; anyone subject to drug testing, especially for the Delta-8 and Delta-9 lines; and anyone with a history of psychosis, schizophrenia or bipolar disorder should avoid the THC products. For the kratom line, additionally: anyone with a seizure disorder, anyone taking opioids, benzodiazepines or alcohol because of additive respiratory depression, anyone with a history of substance use disorder, and anyone in a state where kratom is banned. Do not drive after taking anything intoxicating. This page is information, not medical advice.